TG Therapeutics GAAP EPS of $0.04 beats by $0.09, revenue of $73.47M beats by $7.58M

by
Contributor since / Followers

5 months ago

TG Therapeutics press release (NASDAQ:TGTX): Q2 GAAP EPS of $0.04 beats by $0.09.
Revenue of $73.47M (+357.2% Y/Y) beats by $7.58M.

Tags: TGTX